Literature DB >> 16455728

Irritable bowel syndrome: diagnosis and management.

A Agrawal1, P J Whorwell.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16455728      PMCID： PMC1360402          DOI： 10.1136/bmj.332.7536.280

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  22 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities.

Authors:  G R Locke; A R Zinsmeister; N J Talley; S L Fett; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

Review 3.  Probiotics: an ideal anti-inflammatory treatment for IBS?

Authors:  Robin Spiller
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

Review 4.  Use of psychopharmacological agents for functional gastrointestinal disorders.

Authors:  R E Clouse; P J Lustman
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

5.  Antibiotics increase functional abdominal symptoms.

Authors:  P R Maxwell; E Rink; D Kumar; M A Mendall
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

Review 6.  Tegaserod for the treatment of irritable bowel syndrome.

Authors:  B W Evans; W K Clark; D J Moore; P J Whorwell
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.

Authors:  Brennan M R Spiegel; Vincent P DeRosa; Ian M Gralnek; Victor Wang; Gareth S Dulai
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

9.  Irritable bowel syndrome and surgery: a multivariable analysis.

Authors:  George F Longstreth; Janis F Yao
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

10.  Bran and irritable bowel syndrome: time for reappraisal.

Authors:  C Y Francis; P J Whorwell
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321
View more
  24 in total

1.  Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?

Authors:  James S Pearson; Christine Pollard; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  The challenge of developing new therapies for irritable bowel syndrome.

Authors:  Fernando Azpiroz; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 3.  Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance.

Authors:  J Dalrymple; I Bullock
Journal:  BMJ       Date:  2008-03-08

4.  Designing and delivering a hypnotherapy service for irritable bowel syndrome in primary care.

Authors:  Helen Bremner
Journal:  Frontline Gastroenterol       Date:  2012-05-21

5.  A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

Authors:  Caroline Codling; Liam O'Mahony; Fergus Shanahan; Eamonn M M Quigley; Julian R Marchesi
Journal:  Dig Dis Sci       Date:  2009-08-20       Impact factor: 3.199

6.  State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

Review 7.  Meta-analysis of probiotics for the treatment of irritable bowel syndrome.

Authors:  Lynne V McFarland; Sascha Dublin
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

8.  Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.

Authors:  Michel Dapoigny; Thierry Piche; Philippe Ducrotte; Bernard Lunaud; Jean-Michel Cardot; Annick Bernalier-Donadille
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

9.  Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.

Authors:  Seok-Jae Ko; Bongha Ryu; Jinsung Kim; Beom-Gi Hong; Inkwon Yeo; Beom-Joon Lee; Jin-Moo Lee; Jae-Woo Park
Journal:  Trials       Date:  2011-10-06       Impact factor: 2.279

10.  Impact of shiftwork on irritable bowel syndrome and functional dyspepsia.

Authors:  Hye In Kim; Sung-Ae Jung; Ju Young Choi; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim; Kwon Yoo
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.